Sanofi says its coronavirus vaccine won’t need supercooling
The coronavirus vaccine being developed by Sanofi won’t need to be super-cooled and a normal refrigerator will suffice, the Paris-based drugmaker’s France chief Olivier Bogillot said Sunday.
His comments came days after American pharmaceutical giant Pfizer and its German partner BioNTech announced that their vaccine had proven 90 percent effective in preventing Covid-19 infections in ongoing Phase 3 trials involving more than 40,000 people.
Lagos security: Police raid black spots, arrest 720“This will be an advantage for some countries,” he added.
The Sanofi vaccine, one of many in development, will be available for distribution next June, Bogillot added.
![Guest posting agency=0></a></div><p>The results of the Phase 2 tests, involving hundreds of people, will be made public in early December, he added. If those results are positive then Phase 3 trials involving thousands of people will begin, alongside mass production.</p><p>Eleven of the vaccines under development have already begun Phase 3 trials.</p><p>The Pfizer vaccine is “a little more advanced” in the development process, said Bogillot, but “one laboratory is not going to be able to supply the doses for the whole planet.</p><p>“We will need to have several winners at the end of this race.”</p><p>The Sanofi product will also be made avaiable at an “affordable” price he said, without giving details.</p><p>[AFP]</p><p><a href=http://vanguardngr.com/ ><strong>Vanguard News Nigeria</strong></a></p><p>The post <a rel=nofollow href=https://www.vanguardngr.com/2020/11/sanofi-says-its-coronavirus-vaccine-wont-need-supercooling/ >Sanofi says its coronavirus vaccine won’t need supercooling</a> appeared first on <a rel=nofollow href=https://www.vanguardngr.com/ >Vanguard News</a>.</p><div class=saboxplugin-wrap itemtype=http://schema.org/Person itemscope itemprop=author><div class=saboxplugin-tab><div class=saboxplugin-gravatar><img alt src=](https://i.ibb.co/Tcc2Lcb/Guestposting-336x280-3.jpg)
